Trial intelligence / Profile preview

Quadrivalent influenza vaccine efficacy study in healthy children 6 to 35 months

2013-001231-51Phase 3Completed

Sponsor
Sanofi
Start
Mar 2014
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3 trial of influenza vaccine in influenza (2 arms), sponsored by Sanofi. Primary endpoint: Incidence of laboratory-confirmed influenza associated with protocol-defined influenza-like illness. Started Mar 2014; status: completed.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on 2013-001231-51.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-001231-51.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call